The concentrate

Danaher owns four critical IVD supply nodes

A single conglomerate has consolidated nitrocellulose membranes, oligonucleotide probes, filtration media, and microfluidic components through strategic acquisitions.

The number

4independent critical nodes

Danaher's ownership of Cytiva, IDT, Pall, and IDEX creates a concentration risk across the in-vitro diagnostics manufacturing chain. A single supply disruption—geopolitical, operational, or regulatory—now cascades across multiple independent nodes that diagnostic manufacturers depend on.

Source: Cytiva | Danaher · Danaher Corporation · Jan 1, 2024

Jump into the supply map

Where this story connects

The supplymap lets you trace the goods, inputs, and companies this story touches, see the full dependency chain, country shares, and historical incidents.

Essential goods

Tap to see the full chain

Diagnostic tests and lab supplies →
health
Ophthalmic and eye Rx products →
health
Vaccines →
health

Raw inputs

Tap for sourcing data

0.22-μm Sterilizing-grade Membrane Filters (PVDF/PTFE/PES) →
manufactured
Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes →
manufactured
Nitrocellulose (NC) Membrane for Lateral Flow →
manufactured
Single-Use Bioreactor Bags (Cellbag) →
manufactured

More on Producer · Danaher Corporation / Cytiva (Whatman brand)

Danaher owns four critical IVD supply nodes

Where this story connects

Related stories